I will be speaking at the VC India Conference on Life Sciences and Private Equity

From the VC India Website

Private Equity investments have also seen record growth of about 85% from $1.1 billion in 2004 to $ 2.03 billion in 2005. The VC&PE community’s buoyant confidence in this sector was evident by the fact that the LifeSciences sector emerged as one of the leading recipients of funds accounting for 18% share of all VC&PE investments in 2005.

The Lifesciences Sector is a key growth driver of India ‘s economy and the year 2005 will go down as the year of renaissance for the Lifesciences, bringing fresh vitality and vigour to the industry. Compliance with the TRIPS mandate at the beginning of 2005 has revolutionized the very identity of Indian pharmaceuticals and thrust it down the path of innovation. Today, India Inc. has become an integral part of the global Lifesciences market with a growing share in this space. Cost arbitrage and high quality capabilities are shifting global pharmaceutical attention to India, which could soon make it the pharmaceutical manufacturing hub of the world. Accelerated inroads into the biotech space and a healthcare industry on the verge of a boom, are attracting soaring global awareness presenting a plethora of opportunities.

One Comment

    • Kumar Krishnan

    • 17 years ago

    Hi Ashwin,
    This is interesting. Perhaps we can meet sometime while you are here in Mumbai ? You can email me on the above I.D.
    Best regards,

Leave a Reply

Your email address will not be published. Required fields are marked *